These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 26902031

  • 1. Liver Transplantation for Non-B and Non-C Hepatocellular Carcinoma.
    Kaido T, Mori A, Ogura Y, Hata K, Yoshizawa A, lida T, Yagi S, Uemoto S.
    Hepatogastroenterology; 2015 Jun; 62(140):933-6. PubMed ID: 26902031
    [Abstract] [Full Text] [Related]

  • 2. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K.
    World J Gastroenterol; 2015 Apr 28; 21(16):4933-45. PubMed ID: 25945007
    [Abstract] [Full Text] [Related]

  • 3. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K, Shindoh J, Yamamoto S, Matsuyama Y, Akamatsu N, Arita J, Kaneko J, Sakamoto Y, Hasegawa K, Kokudo N.
    Ann Surg Oncol; 2015 Dec 28; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [Abstract] [Full Text] [Related]

  • 4. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B, Alshebeeb K, Tabrizian P, Marti J, Pierobon ES, Lubezky N, Roayaie S, Florman S, Schwartz ME.
    Ann Surg; 2014 Oct 28; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.
    Utsunomiya T, Shimada M, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Takayama T, Kokudo N, Liver Cancer Study Group of Japan.
    Ann Surg; 2015 Mar 28; 261(3):513-20. PubMed ID: 25072437
    [Abstract] [Full Text] [Related]

  • 6. Differential impact of risk factors for tumor recurrence in hepatitis B and hepatitis C virus-infected patients undergoing liver transplantation for hepatocellular carcinoma.
    Krasnodębski M, Grąt M, Masior Ł, Patkowski W, Krawczyk M.
    Ann Transplant; 2015 Feb 02; 20():70-5. PubMed ID: 25639825
    [Abstract] [Full Text] [Related]

  • 7. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A, Layese R, Magistri P, Gambato M, Colledan M, Magini G, Miglioresi L, Vitale A, Vennarecci G, Ambrosio CD, Burra P, Di Benedetto F, Fagiuoli S, Colasanti M, Maria Ettorre G, Andreoli A, Cillo U, Laurent A, Katsahian S, Audureau E, Roudot-Thoraval F, Duvoux C.
    J Hepatol; 2017 Mar 02; 66(3):552-559. PubMed ID: 27899297
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathologic characteristics of patients with non-B non-C hepatitis virus hepatocellular carcinoma after hepatectomy.
    Kaibori M, Ishizaki M, Matsui K, Kwon AH.
    Am J Surg; 2012 Sep 02; 204(3):300-7. PubMed ID: 22591698
    [Abstract] [Full Text] [Related]

  • 9. Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes.
    Burra P, Germani G, Adam R, Karam V, Marzano A, Lampertico P, Salizzoni M, Filipponi F, Klempnauer JL, Castaing D, Kilic M, Carlis LD, Neuhaus P, Yilmaz S, Paul A, Pinna AD, Burroughs AK, Russo FP.
    J Hepatol; 2013 Feb 02; 58(2):287-96. PubMed ID: 23099188
    [Abstract] [Full Text] [Related]

  • 10. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.
    J Surg Oncol; 2014 Dec 02; 110(8):976-81. PubMed ID: 25171344
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
    Yokoi Y, Suzuki S, Baba S, Inaba K, Konno H, Nakamura S.
    J Gastroenterol; 2005 Mar 02; 40(3):274-82. PubMed ID: 15830287
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological characteristics of patients with non-B non-C hepatocellular carcinoma: a special reference to metabolic syndrome.
    Imura S, Shimada M, Utsunomiya T, Morine Y, Ikemoto T, Mori H, Arakawa Y, Kanamoto M, Iwahashi S, Miyake H.
    Hepatogastroenterology; 2014 Mar 02; 61(129):129-35. PubMed ID: 24895808
    [Abstract] [Full Text] [Related]

  • 13. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.
    Roayaie S, Haim MB, Emre S, Fishbein TM, Sheiner PA, Miller CM, Schwartz ME.
    Ann Surg Oncol; 2000 Dec 02; 7(10):764-70. PubMed ID: 11129425
    [Abstract] [Full Text] [Related]

  • 14. Expression pattern analysis of hepatocellular carcinoma tumor markers in viral hepatitis B and C patients undergoing liver transplantation and resection.
    Ha TY, Hwang S, Kim KH, Lee YJ, Ahn CS, Moon DB, Song GW, Park KM, Kim N, Lee SG.
    Transplant Proc; 2014 Apr 02; 46(3):888-93. PubMed ID: 24767373
    [Abstract] [Full Text] [Related]

  • 15. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY, Hsu CT, Yeh ML, Huang CF, Huang CI, Liang PC, Lin YH, Hsieh MY, Wei YJ, Hsieh MH, Dai CY, Lin ZY, Chen SC, Huang JF, Yu ML, Chuang WL.
    Dig Dis Sci; 2020 Jul 02; 65(7):2120-2129. PubMed ID: 31722058
    [Abstract] [Full Text] [Related]

  • 16. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.
    Liver Transpl; 2007 Jun 02; 13(6):807-13. PubMed ID: 17539001
    [Abstract] [Full Text] [Related]

  • 17. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
    Watabe H, Shiratori Y, Tateishi R, Fujishima T, Akamatsu M, Koike Y, Obi S, Hamamura K, Sato S, Teratani T, Shiina S, Omata M.
    Hepatogastroenterology; 2003 Jun 02; 50(54):2157-60. PubMed ID: 14696486
    [Abstract] [Full Text] [Related]

  • 18. Prognostic impact of des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.
    Harimoto N, Yoshida Y, Kurihara T, Takeishi K, Itoh S, Harada N, Tsujita E, Yamashita YI, Uchiyama H, Soejima Y, Ikegami T, Yoshizumi T, Kawanaka H, Ikeda T, Shirabe K, Saeki H, Oki E, Kimura Y, Maehara Y.
    Transplant Proc; 2015 Apr 02; 47(3):703-4. PubMed ID: 25819732
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas.
    Huo TI, Wu JC, Hsia CY, Chau GY, Lui WY, Huang YH, Lee PC, Chang FY, Lee SD.
    World J Surg; 2004 Aug 02; 28(8):787-91. PubMed ID: 15457359
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
    Aljumah AA, Kuriry H, Faisal N, Alghamdi H.
    Ann Saudi Med; 2018 Aug 02; 38(5):358-365. PubMed ID: 30284991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.